ArticleJAMA oncology2022

Analysis of Outcomes With Addition of Immunotherapy to Chemoradiation Therapy for Non-Small Cell Lung Cancer-Reply.

Salma K Jabbour et al.PubMed ↗Publisher ↗

No numbers read from the abstract.